Related Experiment Video
Updated: Jul 6, 2026
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
[Can cardiovascular diseases be reduced over 80% by a "superpill"? Review on the epidemiological study from Wald and
Insights
The polypill, combining multiple drugs, may overestimate cardiovascular risk reduction. Its use in healthy individuals over 55 is not supported, unlike its role in high-risk patients.
Area of Science:
- Cardiovascular disease prevention
- Pharmacology
- Epidemiology
Context:
- Western diet and lifestyle increase cardiovascular disease (CVD) risk.
- Influencing LDL-cholesterol, blood pressure, and platelet aggregation can mitigate CVD risk.
- The efficacy of lowering serum homocysteine for CVD risk reduction remains unproven.
Purpose:
- To evaluate the proposed benefits and risks of a polypill for cardiovascular disease prevention.
- To critically assess the overestimation of risk reduction associated with polypill use.
- To differentiate the application of polypills in general populations versus high-risk individuals.
Summary:
- A polypill, containing a statin, antihypertensive, folic acid, and aspirin, is suggested to reduce cardiovascular risk.
- The overall risk reduction by a polypill may be overestimated due to lack of established thresholds, potential side effects, drug interactions, and specific indications.
- Combined therapy is established for high-risk patients and secondary prevention, with risk adjustment already in place.
Impact:
- The widespread application of polypills for individuals over 55 without specific indications is questioned.
- The use of effective drugs without proven benefit-risk relationships or medical supervision is not justifiable.
- Current practice supports tailored combination therapy for high-risk patients with atherosclerotic diseases, not a universal polypill approach.
Abstract:
As a consequence of our "western" diet and lifestyle, the risk for cardiovascular diseases is increased in the western world. It can be decreased by influencing the LDL-cholesterol values, the blood pressure and the platelet aggregation. It is, however, not proven that lowering of serum homocysteine levels reduces the risk forcardiovascular diseases. Wald and Law suggest in their epidemiological study a polypill, which has as its ingredients a statin, an anti-hypertonic drug, folic acid, and aspirine. Overall, the risk reduction by a polypill is overestimated, since a threshold is currently not existing, in all drugs side effects and interactions are possible, pharmaceuticals are only labelled for specific indications, and with missing efficacy there could be a negative risk-benefit-relation. Indeed, a combined therapy with different drugs is in place in patients with higher risk and for secondary prevention, which is already risk-adjusted. The use of effective drugs, however, in patients without evidence of a positive risk-benefit-relation and without medical control cannot be justified. Therefore, the application of the polypill for subjects beyond 55 years of age is an illusion; by contrast, treatment of patients with a high risk for atherosclerotic diseases is already reality.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
01:26Coronary Artery Disease IV: Preventive Measures
01:30Coronary Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:28Imaging Studies for Cardiovascular System V: CT